AgingResearch.NewsJoin free

2-aminothiazoline-4-carboxylic acid

2-aminothiazoline-4-carboxylic acid has been studied in 2 papers since 2024: 2 observational studies in people. The newest paper, Jun 12, 2025: “Environmental exposome meets muscle wasting: unraveling the VOC-sarcopenia nexus through urinary metabolomics, inflammatory mediation, and network pharmacology in the NHANES cohort”.

Intervention

2 papers study it1 more mentions it1 findingUpdated

PubChemChEBI

See all 3

“ATCA showing a protective effect against CVD, particularly in older adults and those with hypertension”
Identifying cardiovascular disease risk in the U.S. population using environmental volatile organic compounds exposure: A machine learning predictive model based on the SHAP methodologyEcotoxicology and environmental safety2024doi:10.1016/j.ecoenv.2024.117210

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funder: National Natural Science Foundation of China
  • Humans2

What did studies of 2-aminothiazoline-4-carboxylic acid find?

1

Studies of 2-aminothiazoline-4-carboxylic acid measured 1 outcome; the most studied are cardiovascular disease (1 study).

Cardiovascular disease

downin humans1

1 study

  1. 2-aminothiazoline-4-carboxylic acid protects against cardiovascular disease in humans.

    “ATCA showing a protective effect against CVD, particularly in older adults and those with hypertension”

    Humansolder adults and those with hypertension

    Identifying cardiovascular disease risk in the U.S. population using environmental volatile organic compounds exposure: A machine learning predictive model based on the SHAP methodology

    Ecotoxicology and environmental safety

More on Cardiovascular disease

Latest

Related